Comparison of cryotherapy and nephrectomy in treating implanted VX-2 carcinoma in rabbit kidneys

Stephen Y. Nakada, Travis Jerde, Thomas Warner, Fred T. Lee

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

OBJECTIVE: To compare the efficacy of cryoablation and radical nephrectomy for treating implanted VX-2 carcinoma in rabbit kidneys. MATERIALS AND METHODS: A pilot study was conducted using 27 New Zealand white rabbits to assess the natural history of VX-2 carcinoma in the kidney. VX-2 tumour segments (1 mm 3) were excised from subcutaneous tumours in carrier rabbits and implanted in the left kidney of study rabbits. The tumours were allowed to grow for 6, 7, 8, 9, 10, 14, 18, 21 and 28 days after implantation. Tumour progression was analysed in the kidney and surrounding serosa, and metastatic tumour presence in the lung, liver, spleen and bladder determined. After this, 80 rabbits were implanted with VX-2 in the lower pole and randomized into one of three groups: group 1, 35 rabbits treated 7 days after VX-2 implantation with cryoablation using a 15-min double-freeze technique and a 5-mm tumour margin target temperature of -20°C; group 2, 35 rabbits treated with open radical nephrectomy; or group 3, 10 untreated controls. Rabbits were maintained for 22 days and then killed; the kidneys, lungs, liver, spleen, urinary bladder and ureter were removed, and examined grossly and histologically for tumour presence. RESULTS: In the pilot study there was a consistent 50-100 mm 3 tumour after 7 days of growth, with no evidence of metastatic disease. By day 10 the mean kidney tumour was 230 mm3 and two of three rabbits had metastases in the lung. By day 18 the mean primary tumour was 5504 mm3 and all rabbits had metastatic disease. In the comparison study, cryotherapy cured 66% of implanted rabbits while nephrectomy cured 64%. All untreated controls had significant local and metastatic tumours. Findings in animals killed at 15 days after treatment showed significant differences between both treatment groups and untreated controls (P <0.002). There was no difference in disease-free survival between the cryotherapy and open nephrectomy groups (P = 0.78). CONCLUSION: Both cryoablation and radical nephrectomy were effective in treating implanted VX-2 renal tumours compared with untreated controls. There was no statistically significant difference between cryoablation and nephrectomy.

Original languageEnglish (US)
Pages (from-to)632-636
Number of pages5
JournalBJU International
Volume94
Issue number4
DOIs
StatePublished - Sep 2004
Externally publishedYes

Fingerprint

Cryotherapy
Nephrectomy
Rabbits
Carcinoma
Kidney
Neoplasms
Cryosurgery
Lung
VX
Urinary Bladder
Spleen
Serous Membrane
Liver
Ureter
Natural History
Disease-Free Survival

Keywords

  • Cryotherapy
  • Nephrectomy
  • Renal cancer
  • VX-2 carcinoma

ASJC Scopus subject areas

  • Urology

Cite this

Comparison of cryotherapy and nephrectomy in treating implanted VX-2 carcinoma in rabbit kidneys. / Nakada, Stephen Y.; Jerde, Travis; Warner, Thomas; Lee, Fred T.

In: BJU International, Vol. 94, No. 4, 09.2004, p. 632-636.

Research output: Contribution to journalArticle

Nakada, Stephen Y. ; Jerde, Travis ; Warner, Thomas ; Lee, Fred T. / Comparison of cryotherapy and nephrectomy in treating implanted VX-2 carcinoma in rabbit kidneys. In: BJU International. 2004 ; Vol. 94, No. 4. pp. 632-636.
@article{5617dc33295344b4a99e9dc82246be6c,
title = "Comparison of cryotherapy and nephrectomy in treating implanted VX-2 carcinoma in rabbit kidneys",
abstract = "OBJECTIVE: To compare the efficacy of cryoablation and radical nephrectomy for treating implanted VX-2 carcinoma in rabbit kidneys. MATERIALS AND METHODS: A pilot study was conducted using 27 New Zealand white rabbits to assess the natural history of VX-2 carcinoma in the kidney. VX-2 tumour segments (1 mm 3) were excised from subcutaneous tumours in carrier rabbits and implanted in the left kidney of study rabbits. The tumours were allowed to grow for 6, 7, 8, 9, 10, 14, 18, 21 and 28 days after implantation. Tumour progression was analysed in the kidney and surrounding serosa, and metastatic tumour presence in the lung, liver, spleen and bladder determined. After this, 80 rabbits were implanted with VX-2 in the lower pole and randomized into one of three groups: group 1, 35 rabbits treated 7 days after VX-2 implantation with cryoablation using a 15-min double-freeze technique and a 5-mm tumour margin target temperature of -20°C; group 2, 35 rabbits treated with open radical nephrectomy; or group 3, 10 untreated controls. Rabbits were maintained for 22 days and then killed; the kidneys, lungs, liver, spleen, urinary bladder and ureter were removed, and examined grossly and histologically for tumour presence. RESULTS: In the pilot study there was a consistent 50-100 mm 3 tumour after 7 days of growth, with no evidence of metastatic disease. By day 10 the mean kidney tumour was 230 mm3 and two of three rabbits had metastases in the lung. By day 18 the mean primary tumour was 5504 mm3 and all rabbits had metastatic disease. In the comparison study, cryotherapy cured 66{\%} of implanted rabbits while nephrectomy cured 64{\%}. All untreated controls had significant local and metastatic tumours. Findings in animals killed at 15 days after treatment showed significant differences between both treatment groups and untreated controls (P <0.002). There was no difference in disease-free survival between the cryotherapy and open nephrectomy groups (P = 0.78). CONCLUSION: Both cryoablation and radical nephrectomy were effective in treating implanted VX-2 renal tumours compared with untreated controls. There was no statistically significant difference between cryoablation and nephrectomy.",
keywords = "Cryotherapy, Nephrectomy, Renal cancer, VX-2 carcinoma",
author = "Nakada, {Stephen Y.} and Travis Jerde and Thomas Warner and Lee, {Fred T.}",
year = "2004",
month = "9",
doi = "10.1111/j.1464-410X.2004.05015.x",
language = "English (US)",
volume = "94",
pages = "632--636",
journal = "BJU International",
issn = "1464-4096",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Comparison of cryotherapy and nephrectomy in treating implanted VX-2 carcinoma in rabbit kidneys

AU - Nakada, Stephen Y.

AU - Jerde, Travis

AU - Warner, Thomas

AU - Lee, Fred T.

PY - 2004/9

Y1 - 2004/9

N2 - OBJECTIVE: To compare the efficacy of cryoablation and radical nephrectomy for treating implanted VX-2 carcinoma in rabbit kidneys. MATERIALS AND METHODS: A pilot study was conducted using 27 New Zealand white rabbits to assess the natural history of VX-2 carcinoma in the kidney. VX-2 tumour segments (1 mm 3) were excised from subcutaneous tumours in carrier rabbits and implanted in the left kidney of study rabbits. The tumours were allowed to grow for 6, 7, 8, 9, 10, 14, 18, 21 and 28 days after implantation. Tumour progression was analysed in the kidney and surrounding serosa, and metastatic tumour presence in the lung, liver, spleen and bladder determined. After this, 80 rabbits were implanted with VX-2 in the lower pole and randomized into one of three groups: group 1, 35 rabbits treated 7 days after VX-2 implantation with cryoablation using a 15-min double-freeze technique and a 5-mm tumour margin target temperature of -20°C; group 2, 35 rabbits treated with open radical nephrectomy; or group 3, 10 untreated controls. Rabbits were maintained for 22 days and then killed; the kidneys, lungs, liver, spleen, urinary bladder and ureter were removed, and examined grossly and histologically for tumour presence. RESULTS: In the pilot study there was a consistent 50-100 mm 3 tumour after 7 days of growth, with no evidence of metastatic disease. By day 10 the mean kidney tumour was 230 mm3 and two of three rabbits had metastases in the lung. By day 18 the mean primary tumour was 5504 mm3 and all rabbits had metastatic disease. In the comparison study, cryotherapy cured 66% of implanted rabbits while nephrectomy cured 64%. All untreated controls had significant local and metastatic tumours. Findings in animals killed at 15 days after treatment showed significant differences between both treatment groups and untreated controls (P <0.002). There was no difference in disease-free survival between the cryotherapy and open nephrectomy groups (P = 0.78). CONCLUSION: Both cryoablation and radical nephrectomy were effective in treating implanted VX-2 renal tumours compared with untreated controls. There was no statistically significant difference between cryoablation and nephrectomy.

AB - OBJECTIVE: To compare the efficacy of cryoablation and radical nephrectomy for treating implanted VX-2 carcinoma in rabbit kidneys. MATERIALS AND METHODS: A pilot study was conducted using 27 New Zealand white rabbits to assess the natural history of VX-2 carcinoma in the kidney. VX-2 tumour segments (1 mm 3) were excised from subcutaneous tumours in carrier rabbits and implanted in the left kidney of study rabbits. The tumours were allowed to grow for 6, 7, 8, 9, 10, 14, 18, 21 and 28 days after implantation. Tumour progression was analysed in the kidney and surrounding serosa, and metastatic tumour presence in the lung, liver, spleen and bladder determined. After this, 80 rabbits were implanted with VX-2 in the lower pole and randomized into one of three groups: group 1, 35 rabbits treated 7 days after VX-2 implantation with cryoablation using a 15-min double-freeze technique and a 5-mm tumour margin target temperature of -20°C; group 2, 35 rabbits treated with open radical nephrectomy; or group 3, 10 untreated controls. Rabbits were maintained for 22 days and then killed; the kidneys, lungs, liver, spleen, urinary bladder and ureter were removed, and examined grossly and histologically for tumour presence. RESULTS: In the pilot study there was a consistent 50-100 mm 3 tumour after 7 days of growth, with no evidence of metastatic disease. By day 10 the mean kidney tumour was 230 mm3 and two of three rabbits had metastases in the lung. By day 18 the mean primary tumour was 5504 mm3 and all rabbits had metastatic disease. In the comparison study, cryotherapy cured 66% of implanted rabbits while nephrectomy cured 64%. All untreated controls had significant local and metastatic tumours. Findings in animals killed at 15 days after treatment showed significant differences between both treatment groups and untreated controls (P <0.002). There was no difference in disease-free survival between the cryotherapy and open nephrectomy groups (P = 0.78). CONCLUSION: Both cryoablation and radical nephrectomy were effective in treating implanted VX-2 renal tumours compared with untreated controls. There was no statistically significant difference between cryoablation and nephrectomy.

KW - Cryotherapy

KW - Nephrectomy

KW - Renal cancer

KW - VX-2 carcinoma

UR - http://www.scopus.com/inward/record.url?scp=4544356467&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4544356467&partnerID=8YFLogxK

U2 - 10.1111/j.1464-410X.2004.05015.x

DO - 10.1111/j.1464-410X.2004.05015.x

M3 - Article

VL - 94

SP - 632

EP - 636

JO - BJU International

JF - BJU International

SN - 1464-4096

IS - 4

ER -